Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL).

8100 Background: The benefits of R maintenance after R-based induction as front line therapy, and the patterns of R maintenance use for FL in the US remain undefined. Methods: The National LymphoCa...